VEGFA and neoplasm: As vascular endothelial growth factor (VEGF) is a mediator of angiogenesis related to tumours and conditions like diabetic retinopathy and age-related macular degeneration, anti-VEGF therapy is used in the clinic predominantly for therapy of solid tumours (100, 101).